stoxline Quote Chart Rank Option Currency Glossary
  
(CDX)
  0 (0%)    09-19 15:00
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2024-09-19 2:17:18 PM
Short term     
Mid term     
Targets 6-month :  28.21 1-year :  28.61
Resists First :  24.15 Second :  24.5
Pivot price 23.85
Supports First :  23.6 Second :  19.63
MAs MA(5) :  23.88 MA(20) :  23.84
MA(100) :  23.3 MA(250) :  22.89
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  29.1 D(3) :  34.4
RSI RSI(14): 55.2
52-week High :  25.59 Low :  21.34
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ CDX ] has closed below upper band by 37.6%. Bollinger Bands are 41.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 23.98 - 24.11 24.11 - 24.26
Low: 23.45 - 23.6 23.6 - 23.77
Close: 23.56 - 23.83 23.83 - 24.12
Company Description

The adviser seeks to achieve the fund’s investment objective by investing in high yield bonds also known as “junk bonds” primarily by purchasing exchange traded funds and applying a credit hedge derivatives strategy to the fund’s investments. Under normal circumstances, the fund will invest at least 80% of its net assets in high yield securities. The fund may invest up to 20% of its portfolio in derivatives.

Headline News

Thu, 19 Sep 2024
Companion Diagnostics (CDx) Market – Global Forecasts from 2024 to 2029 - 24matins.uk

Wed, 18 Sep 2024
Credit Risk Gauge Eases as Fed Cuts for First Time in Four Years - Bloomberg

Wed, 18 Sep 2024
GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long - Business Wire

Wed, 18 Sep 2024
How the (CDX) price action is used to our Advantage - Stock Traders Daily

Mon, 16 Sep 2024
EPA Reports Issues with Submitting CBI in CDX for CDR Reporting - JD Supra

Thu, 29 Aug 2024
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for amivantamab-vmjw to identify patients with inoperable or recurrent NSCLC harbouring EGFR exon 20 insertion mutations - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Financial Services
Industry:
Asset Management
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android